Trial Profile
A Phase 4 Study of Efficacy and Safety of Dulaglutide When Added to Insulin Treatment With or Without Oral Antidiabetic Medication in Patients With Type 2 Diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Dulaglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 06 Jul 2018 Status changed from active, no longer recruiting to completed.
- 16 Mar 2018 Planned primary completion date changed from 1 Nov 2017 to 1 Jun 2018.
- 25 May 2017 Planned End Date changed from 1 Jul 2018 to 1 Jun 2018.